ARDS presentation at ATS Conference 5/20 | ATHX Message Board Posts

Athersys, Inc.

  ATHX website

ATHX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1532 of 1539  at  5/14/2019 5:13:57 PM  by

CHM_760


ARDS presentation at ATS Conference 5/20

Dr Bellingan  presented at today's Investor Conference...
 

Dr. Geoff Bellingan is with the University College of London Hospitals. His bio from its website reads:

" Currently Medical Director for Surgery and Cancer board, covering critical care, anaesthesia, theatres, sterile services and medical physics in the Division. I was previously the clinical director for critical care. I am also Reader in Intensive Care Medicine at UCL and theme lead for the critical care and anaesthesia research theme for the Comprehensive Biomedical Research Centre. I am a chest physician who works clinically only in critical care."

Dr. Bellingan's "special interests are in Acute Respiratory Distress Syndrome (ARDS) and in sepsis and inflammation."

 

ATS Conference 2019

May 20, 2019
 
  • Dr. Geoff Bellingan, Medical Director at University College London Hospitals

Dr. Bellingan will present the data from the Athersys ARDS trial. His presentation is titled “Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)” Monday May 20, 2019 9:15 AM - 11:15 AM



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 75
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...